Skip to main content
Clinical Trials/NCT02781233
NCT02781233CompletedNot Applicable

The Impact of Progressive Resistance Training on Quality of Life in Patients With Haemophilia

University of Valencia1 site in 1 country20 target enrollmentStarted: October 24, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
20
Locations
1
Primary Endpoint
Change in Muscle strength

Study Overview

Brief Summary

This study evaluates the clinical impact of a progressive resistance training program in adults patients with haemophilia

Detailed Description

The training program aims improving muscular strength and endurance in the relevant muscles and joints (knee, elbow, ankle, shoulder and hip) in order to improve the quality of life in the patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 60 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •diagnosis of haemophilia A or B
  • •willingness to exercise twice a week during the training program and to complete the pre- and post-program evaluations
  • •approval by their hematologist to participate in the exercise program
  • •age between 18 and 60 years
  • •informed consent signed.

Exclusion Criteria

  • •the inability to attend exercise sessions at least twice a week for 6 consecutive weeks
  • •non adherence to instruction on proper exercise technique
  • •surgical procedures performed 6 weeks prior to or during the exercise program
  • •participation in any other form of exercise, including rehabilitation, during the study; (5) changes in medication during the study
  • •a major bleeding episode that posed a risk or prevented exercise
  • •History of FVIII inhibitor (titer ≥ 0.6 BU [Bethesda unit]) or detectable FVIII inhibitors at screening (titer ≥ 0.4 BU)
  • •Another haemostatic defect
  • •Need for major surgery
  • •Withdrawal of informed consent

Arms & Interventions

Training group

Experimental

Each subject will participate in 2 sessions each week during 8 weeks, with 3 days of difference (rest) between the sessions.

Intervention: Progressive resistance training (Other)

Control group

Placebo Comparator

Usual daily activities

Intervention: Normal daily activities (Other)

Outcomes

Primary Outcomes

Change in Muscle strength

Time Frame: baseline and 8 weeks

For measuring the isometric knee flexion and extension, ankle plantarflexion and dorsiflexion strength and isometric elbow flexion and extension strength, a portable hand-held dynamometer will be used (Nicholas Manual Muscle Tester, Lafayette Instruments, Indiana, USA).

Secondary Outcomes

  • Change in Pain(baseline and 8 weeks)
  • Change in Timed Up and Go(baseline and 8 weeks)
  • Change in Haemophilia Quality of life questionnaire (A36 Haemophilia-QoL® )(baseline and 8 weeks)
  • Change in Bleedings(daily (during the 8 weeks of intervention))
  • Change in viscoelastic properties (rectus femoris)(baseline and 8 weeks)
  • Change in sit-to-stand test(baseline and 8 weeks)
  • Change in Haemophilia Activities List questionnaire(baseline and 8 weeks)
  • Change in The Haemophilia Joint Health Score (HJHS)(baseline and 8 weeks)
  • Change in Kinesiophobia(baseline and 8 weeks)
  • Change in workability index(baseline and 8 weeks)
  • Change in analgesics use (days/week)(baseline and 8 weeks)
  • Change in Range Of Motion (ROM)(baseline and 8 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Felipe Querol Fuentes

Medical doctor, PhD

University of Valencia

Study Sites (1)

Loading locations...

Similar Trials